Navigation Links
Tufts researcher elected 2010 AAAS Fellow for work in superbugs and heat-stable vaccines
Date:1/14/2011

BOSTON (January 14, 2011) Abraham L. (Linc) Sonenshein, PhD, professor of molecular biology and microbiology at Tufts University School of Medicine and member of the genetics and molecular microbiology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts has been awarded the distinction of AAAS Fellow.

Election as a Fellow is an honor bestowed upon AAAS members by their peers. Fellows are awarded because of their scientifically or socially distinguished efforts to advance science or its applications. Sonenshein was elected for his distinguished contributions to the understanding of gene regulation, sporulation and pathogenesis in Gram-positive bacteria.

Sonenshein, who is also the acting chair of molecular biology and microbiology at Tufts School of Medicine, studies the regulation of gene transcription in the spore-forming bacteria Bacillus subtilis and Clostridium difficile, and the relationship of sporulation to pathogenesis.

His work with the "superbug," C. difficile which causes severe diarrhea in patients and sometimes death, showed that the bacteria only produce toxins when they are limited for nutrients. Essentially, protein that monitors the nutrient levels inside C. difficile cells prevents toxin production when the bacteria have enough to eat.

This and his other work with C. difficile are important steps toward the development of a drug that may prevent hospital patients from falling ill.

In ongoing work, he is collaborating with scientists at the Cummings School of Veterinary Medicine at Tufts and Boston University to use the harmless B. subtilis bacterium as the basis for low-cost, needle-free and heat-stable vaccines. In a study published in the November 2010 issue of Clinical and Vaccine Immunology, one such vaccine using nasal drops instead of needles effectively induced an immune response in mice and protected them from rotavirus infection. Rotavirus is a common cause of severe diarrheal disease that is responsible for approximately 500,000 deaths among children in the developing world every year.

The new vaccine delivery system has also been tested successfully against tetanus. A study published in Vaccine in September 2010 established that the tetanus vaccine is effective even after being stored for more than a year at 113F. The new vaccine delivery system is currently being tested with diphtheria and pertussis.


'/>"/>

Contact: Siobhan E. Gallagher
617-636-6586
Tufts University, Health Sciences
Source:Eurekalert

Related medicine news :

1. Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions
2. Impressive lineup of speakers at Tufts nutrition conference
3. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
4. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
5. Researchers discover new way to kill pediatric brain tumors
6. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
7. Tiny fruit fly could offer big clues in fight against obesity, researcher says
8. Researchers create drug to keep tumor growth switched off
9. MSU researcher linking breast cancer patients with alternative therapies
10. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
11. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology: